Search Results - "Rechenmacher, Michael"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue by Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Pukrop, Tobias, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher, Reichle, Albrecht

    “…In most clinical trials, thiazolidinediones do not show any relevant anti-cancer activity when used as mono-therapy. Clinical inefficacy contrasts ambiguous…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Low-density lipoprotein balances T cell metabolism and enhances response to anti-PD-1 blockade in a HCT116 spheroid model by Babl, Nathalie, Hofbauer, Joshua, Matos, Carina, Voll, Florian, Menevse, Ayse Nur, Rechenmacher, Michael, Mair, Ruth, Beckhove, Philipp, Herr, Wolfgang, Siska, Peter J, Renner, Kathrin, Kreutz, Marina, Schnell, Annette

    Published in Frontiers in oncology (27-01-2023)
    “…The discovery of immune checkpoints and the development of their specific inhibitors was acclaimed as a major breakthrough in cancer therapy. However, only a…”
    Get full text
    Journal Article
  4. 4

    Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis by Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Thomas, Simone, Pukrop, Tobias, Hackl, Christina, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher, Reichle, Albrecht

    Published in Frontiers in pharmacology (28-11-2018)
    “…Classic tumor therapy, consisting of cytotoxic agents and/or targeted therapy, has not overcome therapeutic limitations like poor risk genetic parameters,…”
    Get full text
    Journal Article
  5. 5

    Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy by Hofbauer, Joshua, Hauck, Andreas, Matos, Carina, Babl, Nathalie, Decking, Sonja-Maria, Rechenmacher, Michael, Schulz, Christian, Regotta, Sabine, Mickler, Marion, Haferkamp, Sebastian, Siska, Peter J, Herr, Wolfgang, Renner, Kathrin, Kreutz, Marina, Schnell, Annette

    Published in Biomolecules (Basel, Switzerland) (18-05-2022)
    “…Although the discovery of immune checkpoints was hailed as a major breakthrough in cancer therapy, generating a sufficient response to immunotherapy is still…”
    Get full text
    Journal Article
  6. 6

    Determinants of completion of advance directives: a cross-sectional comparison of 649 outpatients from private practices versus 2158 outpatients from a university clinic by Pfirstinger, Jochen, Bleyer, Bernhard, Blum, Christian, Rechenmacher, Michael, Wiese, Christoph H, Gruber, Hans

    Published in BMJ open (01-12-2017)
    “…ObjectivesTo compare outpatients from private practices and outpatients from a university clinic regarding the determinants of completion of advance directives…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report by Niessen, Christoph, Jung, Ernst-Michael, Schreyer, Andreas G, Wohlgemuth, Walter A, Trabold, Benedikt, Hahn, Joachim, Rechenmacher, Michael, Stroszczynski, Christian, Wiggermann, Philipp

    Published in Journal of medical case reports (13-05-2013)
    “…Irreversible electroporation (IRE) is a new minimally invasive tumor ablation technique which induces irreversible disruption of cell membrane integrity by…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Therapie von Thymomen und Thymuskarzinomen by Ried, Michael, Rechenmacher, Michael, Dietl, Barbara, Marx, Alexander, Hamer, Okka W., Schalke, Berthold, Kirzinger, Lukas, Hofmann, Hans-Stefan

    Published in Best practice onkologie (01-09-2017)
    “…Zusammenfassung Hintergrund Thymome und Thymuskarzinome (TK) zählen zu den häufigsten primären malignen Raumforderungen im vorderen Mediastinum. Ziel der…”
    Get full text
    Journal Article